益生菌和消化酶的区别与作用：益生菌和消化酶可以如何帮助恢复平衡
您的肠道感觉像不像一个“战场”？
对很多人来说，
答案是肯定的。
许多人可能通过改变饮食、
服用益生菌和/或补充消化酶
来部分或完全解决肠胃问题。
2000多年前，
希波克拉底说过：
“所有的疾病都始于肠道”。
不仅要了解肠道问题的根源，
还要了解益生菌和消化酶可能如何帮助恢复平衡。
益生菌的作用
我们的肠道失去了数千种细菌菌株重要的多样性，
这些细菌菌株寄生在我们的肠道中并维持我们的健康。
此外，
我们的快餐饮食和衰老也影响着我们的肠道健康。
无论一个人的生活方式有多大的改变，
如果不使用益生菌补充剂，
他们可能无法完全恢复肠道细菌的多样性。
一旦消除了有害的诱因，
益生菌可以通过重新补充有益的肠道细菌
并恢复肠道群落的平衡来帮助改善肠道健康。
使用消化酶补充剂也可改善肠道健康
针对食物不耐受的另一种方法是
使用消化酶补充剂来部分或完全解决肠胃问题。
使用消化酶补充剂的主要理念是
它们将可能难以耐受的食物成分分解成更容易消化的物质。
其目的是帮助人们避免产生胀气、
腹胀或腹泻等常见副作用。
虽然避免食物诱发是理想的方法，
但有时这并不总是可行的。
益生菌可能具有更广泛的益处，
例如恢复肠道细菌；
然而使用消化酶
对抗肠道疾病的效果范围可能却非常有限。
补充消化酶的目的是
分解难耐受或难消化的食物。
目前，
消化酶的使用还未像益生菌补充剂那样在医学上得到认可，
但多项研究表明，
它可能有助于缓解
由于食物耐受不良而导致的肠易激综合征（IBS）
和腹胀等胃肠道疾病。
参考：
1.Milligan, Phylllis. “New Survey Reveals More than Half of Americans Are Living with Gastrointestinal Symptoms and Not Seeking Care from a Doctor.” New Survey Reveals More than Half of Americans Are Living with Gastrointestinal Symptoms and Not Seeking Care from a Doctor | AbbVie News Center, 2013, http://news.abbvie.com/news/new-survey-reveals-more-than-half-americans-are-living-with-gastrointestinal-symptoms-and-not-seeking-care-from-doctor.htm.
2.Mössner, Joachim, and Volker Keim. “Pancreatic Enzyme Therapy.” Deutsches Aerzteblatt Online, 2011, doi:10.3238/arztebl.2011.0578.
3.Smits, Samuel A., et al. “Seasonal Cycling in the Gut Microbiome of the Hadza Hunter-Gatherers of Tanzania.” Science, vol. 357, no. 6353, 2017, pp. 802–806., doi:10.1126/science.aan4834.
4.Barbut, F. “Managing Antibiotic Associated Diarrhoea.” Bmj, vol. 324, no. 7350, 2002, pp. 1345–1346., doi:10.1136/bmj.324.7350.1345.
5.Ianiro, Gianluca, et al. “Digestive Enzyme Supplementation in Gastrointestinal Diseases.” Current Drug Metabolism, vol. 17, no. 2, 2016, pp. 187–193., doi:10.2174/138920021702160114150137.
6.Kaur, Nirmal, et al. “Intestinal Dysbiosis in Inflammatory Bowel Disease.” Gut Microbes, vol. 2, no. 4, 2011, pp. 211–216., doi:10.4161/gmic.2.4.17863.
7.Nath, Arijit, et al. “Biological Activities of Lactose-Based Prebiotics and Symbiosis with Probiotics on Controlling Osteoporosis, Blood-Lipid and Glucose Levels.” Medicina, vol. 54, no. 6, 2018, p. 98., doi:10.3390/medicina54060098.
8.Liu, Yuying, et al. “Probiotics in Autoimmune and Inflammatory Disorders.” Nutrients, vol. 10, no. 10, 2018, p. 1537., doi:10.3390/nu10101537.
9.Ciorba, Matthew A. “A Gastroenterologist's Guide to Probiotics.” Clinical Gastroenterology and Hepatology, vol. 10, no. 9, 2012, pp. 960–968., doi:10.1016/j.cgh.2012.03.024.
10.Tsai, Yu-Ling, et al. “Probiotics, Prebiotics and Amelioration of Diseases.” Journal of Biomedical Science, vol. 26, no. 1, 2019, doi:10.1186/s12929-018-0493-6.
11.Liu, Yuying, et al. “Probiotics in Autoimmune and Inflammatory Disorders.” Nutrients, vol. 10, no. 10, 2018, p. 1537., doi:10.3390/nu10101537.
12.Fuller, R. “Probiotics in Human Medicine.” Gut, vol. 32, no. 4, 1991, pp. 439–442., doi:10.1136/gut.32.4.439.
13.Jia, Kai, et al. “The Clinical Effects of Probiotics for Inflammatory Bowel Disease.” Medicine, vol. 97, no. 51, 2018, doi:10.1097/md.0000000000013792.
14.Kaur, Nirmal, et al. “Intestinal Dysbiosis in Inflammatory Bowel Disease.” Gut Microbes, vol. 2, no. 4, 2011, pp. 211–216., doi:10.4161/gmic.2.4.17863.
15.Sniffen, Jason C., et al. “Choosing an Appropriate Probiotic Product for Your Patient:An Evidence-Based Practical Guide.” Plos One, vol. 13, no. 12, 2018, doi:10.1371/journal.pone.0209205.
16.Ianiro, Gianluca, et al. “Digestive Enzyme Supplementation in Gastrointestinal Diseases.” Current Drug Metabolism, vol. 17, no. 2, 2016, pp. 187–193., doi:10.2174/138920021702160114150137.
17.Löhr, J.‐M., et al. “The Ageing Pancreas: a Systematic Review of the Evidence and Analysis of the Consequences.” Journal of Internal Medicine, John Wiley & Sons, Ltd (10.1111), 23 Mar. 2018, http://onlinelibrary.wiley.com/doi/abs/10.1111/joim.12745.
18.Spagnuolo, R., et al. “P.07.12 Beta-Glucan, Inositol And Digestive Enzymes In Patients With Inflammatory Bowel Disease Associated With Irritable Bowel Syndrome.” Digestive and Liver Disease, vol. 48, 2016, doi:10.1016/s1590-8658(16)30228-6.
19.Mitea, C, et al. “Efficient Degradation of Gluten by a Prolyl Endoprotease in a Gastrointestinal Model:Implications for Coeliac Disease.” Gut, vol. 57, no. 1, 2007, pp. 25–32., doi:10.1136/gut.2006.111609.
